Viewing Study NCT06342960


Ignite Creation Date: 2025-12-25 @ 2:06 AM
Ignite Modification Date: 2026-03-05 @ 7:36 AM
Study NCT ID: NCT06342960
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-29
First Post: 2024-03-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: KYSA-3: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis
Sponsor:
Organization: